Namenda
NDC Package 0456-3421-33

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Namenda is memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. Marketed by Allergan, Inc., this product is identified by NDC 0456-3421 and is authorized under FDA application NDA022525.

Identification & Billing

NDC Package Code
0456-3421-33
Package Description
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Product Code
0456-3421
11-Digit Billing Format
00456342133
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA

Clinical Specifications

Proprietary Name
Namenda XR
Dosage Form
-
Usage Information
Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease.

Regulatory & Marketing

Labeler Name
Allergan, Inc.
FDA Application #
NDA022525
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-31-2011
End Marketing Date
10-31-2024
Listing Expiration
10-31-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0456-3421-33 identifies a specific commercial package of 30 capsule, extended release in 1 bottle of Namenda XR, labeled by Allergan, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Allergan, Inc. on October 31, 2011. The current certification is valid through October 31, 2024.

What are the primary indications for this medication?

Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease.

How is this Allergan, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00456342133. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0456-3421-33
11-Digit CMS (5-4-2)
00456-3421-33

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.